Cargando…

Health‐related quality of life in people with type 2 diabetes participating in the LEADER trial

AIMS: To assess health‐related quality of life (HRQoL) in people with type 2 diabetes (T2D) participating in the LEADER cardiovascular outcomes trial using the five‐dimension European Quality of Life questionnaire (EQ‐5D). MATERIALS AND METHODS: The EQ‐5D was administered every 12 months in a subset...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nauck, Michael A., Buse, John B., Mann, Johannes F. E., Pocock, Stuart, Bosch‐Traberg, Heidrun, Frimer‐Larsen, Helle, Ye, Qing, Gray, Alastair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587748/ https://www.ncbi.nlm.nih.gov/pubmed/30260088 http://dx.doi.org/10.1111/dom.13547

Ejemplares similares

Liraglutide and Glycaemic Outcomes in the LEADER Trial
por: Zinman, Bernard, et al.
Publicado: (2018)

Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial
por: Tack, Cees J., et al.
Publicado: (2019)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations
por: Daniels, G H, et al.
Publicado: (2015)

LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial
por: Steinberg, William M., et al.
Publicado: (2014)

LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ
por: Rutten, Guy E. H. M., et al.
Publicado: (2016)

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials
por: Verma, Subodh, et al.
Publicado: (2020)

Safety and efficacy of the combination of the glucagon‐like peptide‐1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post‐hoc analysis of a randomized, 52‐week, open‐label, parallel‐group trial
por: Kiyosue, Arihiro, et al.
Publicado: (2017)

Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of a phase 3 randomized clinical trial
por: Kaneko, Shizuka, et al.
Publicado: (2018)

Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
por: Rossing, Peter, et al.
Publicado: (2023)

A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg
por: Seino, Yutaka, et al.
Publicado: (2022)

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
por: Rossing, Peter, et al.
Publicado: (2023)

Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
por: Shaman, Ahmed M., et al.
Publicado: (2021)

Meaning in Life and Meaningful Engagement in the Moment: Lives of Prosocial Leaders and Volunteers
por: Nakamura, Jeanne, et al.
Publicado: (2020)

Why People Believe in Their Leaders - Or Not
por: Chng, Daniel
Publicado: (2018)

The Leader's Guide to Managing People
por: Brent, Mike
Publicado: (2013)

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920
por: Nauck, Michael A., et al.
Publicado: (2020)

Health Literacy among People in Cardiac Rehabilitation: Associations with Participation and Health-Related Quality of Life in the Heart Skills Study in Denmark
por: Aaby, Anna, et al.
Publicado: (2020)

Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52‐week, open‐label, parallel‐group trial
por: Kaku, Kohei, et al.
Publicado: (2015)

Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36‐week, randomized, double‐blind, parallel‐group trial
por: Seino, Yutaka, et al.
Publicado: (2016)

Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN‐6 cardiovascular outcomes trials
por: Kahkoska, Anna R., et al.
Publicado: (2020)

The impact of diagnosis on health-related quality of life in people with coeliac disease: a UK population-based longitudinal perspective
por: Violato, Mara, et al.
Publicado: (2019)

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
por: Verma, Subodh, et al.
Publicado: (2019)

The Professional Quality of Life and Work Engagement of Nurse Leaders
por: Remegio, Warly, et al.
Publicado: (2021)

Thought Leader Perspectives on Participant Protections in Precision Medicine Research
por: Hammack, Catherine M., et al.
Publicado: (2019)

Corrigendum to The Professional Quality of Life and Work Engagement of Nurse Leaders [Nurse Leader 19 (2021) 95-100]
por: Remegio, Warly, et al.
Publicado: (2022)

Young people are experts and leaders in the HIV response
por: Rufurwadzo, Tinashe G, et al.
Publicado: (2020)

Extent of East-African Nurse Leaders' Participation in Health Policy Development
por: Shariff, N., et al.
Publicado: (2012)

The quality of life of patients with genital warts: a qualitative study
por: Mortensen, Gitte Lee, et al.
Publicado: (2010)

Factors associated with participation in life situations in people with COPD
por: D’Amore, Cassandra, et al.
Publicado: (2022)

The prosperous leader: how smart people achieve success
por: Engel, Jacob M, et al.
Publicado: (2014)

Coaching Leaders: Guiding People Who Guide Others
por: White, Daniel
Publicado: (2013)

Quality of life of homosexual males with genital warts: a qualitative study
por: Lee Mortensen, Gitte, et al.
Publicado: (2010)

Structural analysis of leader peptide binding enables leader-free cyanobactin processing
por: Koehnke, Jesko, et al.
Publicado: (2015)

Factors that act as facilitators and barriers to nurse leaders’ participation in health policy development
por: Shariff, Nilufa
Publicado: (2014)

Growing leaders from below: Identity‐based worker education and identity‐leader ability among self‐employed women in India
por: Jay, Sarah, et al.
Publicado: (2022)

Credibility: how leaders gain and lose it, why people demand it
por: Kouzes, James M, et al.
Publicado: (1995)

How To Make Good People Great Leaders: And Reap the Rewards!
por: Nowak, Ricky
Publicado: (2011)

The busy leader's handbook: how to lead people and places that thrive
por: Studer, Quint
Publicado: (2019)

Credibility: How Leaders Gain and Lose It: Why People Demand it
por: Kouzes, James
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jihjdipbi34tk6fg76om3tld98